This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

M. H. Nathan, MD; Kathy Domanski, RT
Scottsdale Memorial Hospital Scottsdale, Ariz

JAMA. 1978;239(9):831-833.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

With the advent of ultrasound and body computerized tomography (CT) scanning, radionuclide imaging of the pancreas is rapidly being replaced. However, there are still many hospitals where CT scanning or newer Grey-scale ultrasound is not available and where pancreatic radionuclide imaging is still being performed. Rodriguez-Antunez et al¹ were correct in 96% of 107 pancreatic scans interpreted as normal and had a 57% accuracy in those reported as abnormal. Sodee² had a diagnostic accuracy of 94% among 220 scans interpreted either as normal or abnormal. Most investigators agree that there is about a 92% accuracy when the pancreatic scan is reported normal but only about 51% accuracy when reported abnormal.³

The radioactive imaging agent used in pancreatic scanning is selenomethionine Se 75, which is incorporated into the pancreatic enzymes. Unfortunately, in addition to radioactive labeling of the pancreas in this process, the liver also . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?